Key facts
| Price (PPV) | 135 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amlodipinevalsartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DB01 |
| Manufacturer | COOPER PHARMA |
| Presentation | Boite de 30 |
| Hospital price | 84.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle essentielle. L’association amlodipine-valsartan est indiquée chez les patients dont la tension artérielle est insuffisamment contrôlée par le valsartan seul ou par l'amlodipine seule. L’association amlodipine-valsartan est indiquée pour le traitement initial de l'hypertension artérielle. La décision de prescrire L’association amlodipine-valsartan en traitement initial de l'hypertension artérielle doit reposer sur une évaluation des bénéfices et des risques potentiels.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Suliat 5 mg / 80 mg (AFRIC-PHAR) contains the same active substance as Valmep 5 mg / 80 mg (Amlodipine | Valsartan) at the same strength, but in a different pack: Boite de 14 at 86.10 MAD, i.e. 6.15 MAD per unit against 4.50 MAD for Valmep 5 mg / 80 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Suliat 5 mg / 80 mg | AFRIC-PHAR | Boite de 14 | 86.10 MAD | 6.15 / unit |
| Suliat 5 mg / 80 mg | AFRIC-PHAR | Boite de 28 | 151.60 MAD | 5.41 / unit |
| Xilam 5 mg / 80 mg | SOTHEMA | Boite de 28 | 151.60 MAD | 5.41 / unit |
| Exforge 5 mg / 80 mg | NOVARTIS PHARMA MAROC | Boîte de 28 | 195 MAD | 6.96 / unit |
| Suliat 5 mg / 80 mg | AFRIC-PHAR | Boite de 56 | 267 MAD | 4.77 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Valmep 5 mg / 80 mg
Valmep 5 mg / 80 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by COOPER PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Valmep 5 mg / 80 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Valmep 5 mg / 80 mg
Answers to common questions from Moroccan patients about this drug.